Literature DB >> 23359703

Involvement of Toso in activation of monocytes, macrophages, and granulocytes.

Karl S Lang1, Philipp A Lang, Andreas Meryk, Aleksandra A Pandyra, Louis-Martin Boucher, Vitaly I Pozdeev, Michael W Tusche, Joachim R Göthert, Jillian Haight, Andrew Wakeham, Annick J You-Ten, David R McIlwain, Katja Merches, Vishal Khairnar, Mike Recher, Garry P Nolan, Yasumichi Hitoshi, Pauline Funkner, Alexander A Navarini, Admar Verschoor, Namir Shaabani, Nadine Honke, Linda Z Penn, Pamela S Ohashi, Dieter Häussinger, Kyeong-Hee Lee, Tak W Mak.   

Abstract

Rapid activation of immune responses is necessary for antibacterial defense, but excessive immune activation can result in life-threatening septic shock. Understanding how these processes are balanced may provide novel therapeutic potential in treating inflammatory disease. Fc receptors are crucial for innate immune activation. However, the role of the putative Fc receptor for IgM, known as Toso/Faim3, has to this point been unclear. In this study, we generated Toso-deficient mice and used them to uncover a critical regulatory function of Toso in innate immune activation. Development of innate immune cells was intact in the absence of Toso, but Toso-deficient neutrophils exhibited more reactive oxygen species production and reduced phagocytosis of pathogens compared with controls. Cytokine production was also decreased in Toso(-/-) mice compared with WT animals, rendering them resistant to septic shock induced by lipopolysaccharide. However, Toso(-/-) mice also displayed limited cytokine production after infection with the bacterium Listeria monocytogenes that was correlated with elevated presence of Listeria throughout the body. Accordingly, Toso(-/-) mice succumbed to infections of L. monocytogenes, whereas WT mice successfully eliminated the infection. Taken together, our data reveal Toso to be a unique regulator of innate immune responses during bacterial infection and septic shock.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359703      PMCID: PMC3574925          DOI: 10.1073/pnas.1222264110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Integrins limit the Toll.

Authors:  Terry K Means; Andrew D Luster
Journal:  Nat Immunol       Date:  2010-08       Impact factor: 25.606

2.  SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL.

Authors:  Rodrigo Proto-Siqueira; Rodrigo A Panepucci; Francisco P Careta; Abigail Lee; Andrew Clear; Kelly Morris; Carolyn Owen; Edgar G Rizzatti; Wilson A Silva; Roberto P Falcão; Marco A Zago; John G Gribben
Journal:  Blood       Date:  2008-04-23       Impact factor: 22.113

Review 3.  Neutrophils: warriors and commanders in immune mediated inflammatory diseases.

Authors:  R Cascão; H S Rosário; J E Fonseca
Journal:  Acta Reumatol Port       Date:  2009 Apr-Jun       Impact factor: 1.290

4.  Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.

Authors:  Junichi Hirahashi; Keiichi Hishikawa; Shinya Kaname; Naotake Tsuboi; Yunmei Wang; Daniel I Simon; George Stavrakis; Tatsuo Shimosawa; Ling Xiao; Yutaka Nagahama; Kazuo Suzuki; Toshiro Fujita; Tanya N Mayadas
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

5.  Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.

Authors:  Chaofeng Han; Jing Jin; Sheng Xu; Haibo Liu; Nan Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-07-18       Impact factor: 25.606

6.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.

Authors:  Naotake Tsuboi; Kenichi Asano; Michael Lauterbach; Tanya N Mayadas
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

Review 7.  Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.

Authors:  Renate Kain; Dawn A Firmin; Andrew J Rees
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

8.  Identification of TOSO/FAIM3 as an Fc receptor for IgM.

Authors:  Hideaki Shima; Hiroyuki Takatsu; Shinji Fukuda; Masumi Ohmae; Koji Hase; Hiromi Kubagawa; Ji-Yang Wang; Hiroshi Ohno
Journal:  Int Immunol       Date:  2009-12-30       Impact factor: 4.823

Review 9.  Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.

Authors:  Tanya N Mayadas; George C Tsokos; Naotake Tsuboi
Journal:  Circulation       Date:  2009-11-17       Impact factor: 29.690

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more
  31 in total

1.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.

Authors:  Jellert T Gaublomme; Nir Yosef; Youjin Lee; Rona S Gertner; Li V Yang; Chuan Wu; Pier Paolo Pandolfi; Tak Mak; Rahul Satija; Alex K Shalek; Vijay K Kuchroo; Hongkun Park; Aviv Regev
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

2.  Reply to Honjo et al.: Functional relevant expression of Toso on granulocytes.

Authors:  Karl S Lang; Philipp A Lang; Andreas Meryk; Aleksandra A Pandyra; Katja Merches; Kyeong-Hee Lee; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

3.  Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.

Authors:  Chih-Hang Tang; Shiun Chang; Ayumi Hashimoto; Yi-Ju Chen; Chang Won Kang; Anthony R Mato; Juan R Del Valle; Dmitry I Gabrilovich; Chih-Chi Hu
Journal:  Cancer Immunol Res       Date:  2018-04-12       Impact factor: 11.151

4.  Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.

Authors:  P A Lang; A Meryk; A A Pandyra; D Brenner; A Brüstle; H C Xu; K Merches; F Lang; V Khairnar; P Sharma; P Funkner; M Recher; N Shaabani; G S Duncan; V Duhan; B Homey; P S Ohashi; D Häussinger; P A Knolle; N Honke; T W Mak; K S Lang
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

Review 5.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

6.  Surface receptor Toso controls B cell-mediated regulation of T cell immunity.

Authors:  Jinbo Yu; Vu Huy Hoang Duong; Katrin Westphal; Andreas Westphal; Abdulhadi Suwandi; Guntram A Grassl; Korbinian Brand; Andrew C Chan; Niko Föger; Kyeong-Hee Lee
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

7.  Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cells.

Authors:  Dirk Brenner; Anne Brüstle; Gloria H Y Lin; Philipp A Lang; Gordon S Duncan; Christiane B Knobbe-Thomsen; Michael St Paul; Colin Reardon; Michael W Tusche; Bryan Snow; Sara R Hamilton; Aline Pfefferle; Syed O Gilani; Pamela S Ohashi; Karl S Lang; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

Review 8.  Targeting the Fc receptor in autoimmune disease.

Authors:  Xinrui Li; Robert P Kimberly
Journal:  Expert Opin Ther Targets       Date:  2014-03       Impact factor: 6.902

9.  Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Yusuke Suzuki; Miyuki Takagi; Hiroshi Ohno; R Pat Bucy; Shozo Izui; Hiromi Kubagawa
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

10.  Is Toso/IgM Fc receptor (FcμR) expressed by innate immune cells?

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Hiromi Kubagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.